Bombardier (TSX:BBD.B) Stock: Is a Recovery Possible?

Bombardier (TSX:BBD.B) currently trades near its all-time low. Is the stock oversold?

| More on:
question marks written reminders tickets

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Bombardier (TSX:BBD.B) took a major hit in recent months. While the stock already faced strong headwinds due to its debt load, the impact of the pandemic has contrarian investors wondering if the company will survive.

Asset liquidation

Bombardier spent the past few years selling off its entire commercial airline assets. The exit from the sector marks the end of a disappointing effort by the company to secure its position of a global leader in the production of small and medium-sized aircraft.

The CSeries jets held great promise for Bombardier. The new planes offered industry-leading fuel efficiency, attracting significant interest from global airlines when oil prices hovered near US$100 per barrel back in 2014.

Had Bombardier been able to meet its initial production and delivery targets for the first CSeries customers, the company could have racked up a massive order book. Unfortunately, the CSeries program ran into serious delays and production troubles. Bombardier missed a number of delivery targets, frustrating early buyers of the new planes and deterring new ones from placing orders.

Customers normally don’t pay for the planes until they take delivery. The delays put a major dent in anticipated revenue. Given the significant cost of a new jet, the revenue drop forced Bombardier to take on significant debt. In addition, running a number of years behind schedule drove up development and production costs. As a result, Bombardier burned through significant cash flow.

Revenue from the other plane divisions and the rail business couldn’t cover the massive losses racked up by the CSeries. The company required US$2.5 billion in emergency aid from the Quebec government and the province’s pension fund. Bombardier employs thousands of people in Quebec and saving these skilled and high-paying jobs is a priority for the government.

Rescue plan

The board shelved the dividend and brought in new management to try to right the ship. Bombardier’s share price went from $0.80 in early 2016 to $5.40 in the summer of 2018, but the good times didn’t last long.

In the end, Bombardier sold its entire stake in the CSeries to Airbus. The company also sold off its turboprop division, its CRJ jet business, and its aerostructures group. These deals have either closed or are expected to close by the end of 2020.

Earlier this year, Bombardier announced plans to sell its rail division to Alstom. That deal could close by the middle of 2021.

Business jet bet

Assuming the rail deal goes through as agreed, Bombardier is left with its business jet group. New planes and steady demand held good promise for the division heading into 2020.

The arrival of the COVID-19 pandemic puts the future of the business jet division in question.

Should you buy Bombardier stock today?

Once travel restrictions ease around the globe, demand might surge for the small planes as wealthy individuals and companies turn to private jets to avoid the potential health risks of flying on large commercial planes.

That said, business jet success still might not be able to dig Bombardier out of its debt problems.

The company finished Q2 2020 with US$1.7 billion in cash and US$2.5 billion in liquidity. The anticipated closing of the aerostructures unit should add US$500 million to the cash position.

In the Q2 report Bombardier said it expects to have enough cash to meet obligations for the next 12 months, based on current access to capital and anticipated proceeds from asset sales.

Long-term debt as of June 30 sat at U$8.95 billion. Bombardier has US$1.485 billion coming due in 2021. Another US$1.7 billion is due in 2022, followed by US$1.25 billion in 2023, US$1 billion in 2024, and US$1.5 billion in 2025.

It is uncertain whether Bombardier will be able to issue new debt to replace the maturing notes. If it succeeds, there is still a question of cash flow.

Investors have to decide whether they think the business jet group can save the company.

At this point, nimble traders might be able to make a fast buck on positive price moves. Buy-and-hold investors should probably consider other opportunities today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Walker has no position in any stock mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »